Advocacy & Policy

The Food and Drug Administration (FDA) and the National Institutes of Health (NIH) hosted the Regenerative Medicine Innovation Workshop on Dec. 6-7, 2017, in Ro

The AAMC Nov. 17 joined a community letter, coordinated by the National Association for Biomedical Research, to House and Senate Appropriations Committee Chairs

Community letter, coordinated by the National Association for Biomedical Research, to House and Senate Appropriations Chairs in opposition to H.R. 3197, the “PU

—Three research and industry institutions Nov. 14 testified before the Senate Health, Education, Labor, and Pensions (HELP) Committee about the role of gene edi

House and Senate negotiators Nov. 8 agreed to remove language in the National Defense Authorization Act (NDAA) for fiscal year (FY) 2018 that would restrict the

The AAMC and four other higher education associations Nov. 6 sent a letter to Environmental Protection Agency (EPA) Administrator Scott Pruitt opposing a new po

AAMC partnered with the American Council on Education, the Association of American Universities, the Association of Public and Land-grant Universities, and the

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors met Oct. 30 to approve funding for a $9 million new study comparing two approaches t

Letter requesting the enactment of a bicameral, bipartisan fiscal year (FY) 2018 budget agreement that raises the spending caps and enables a $36.1 billion inve

The AAMC supports legislation representing a milestone toward extending funding for the CHIP program and critical workforce programs administered by HRSA.